Alivus Life Sciences Limited

Web: glenmarklifesciences.com NSE: ALIVUS BSE: 543322 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

1105 14(1%)

Volume

27k as on 30, Oct

Open

1,073

High

0

Low

0

Close

1,091

VWAP

910

52 Week High

1,225

52 Week Low

819

Viand Research Rating
Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

13,563

No. of Shares

12.3

P/E

-

P/B

-

Face Value

-

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-

ROCE

-

Profit Growth

-

Listing Date

06-Aug-21

Promoter Holding

74.87%

FII Holding

5.3%

DII Holding

7.27%

Price Chart
Price Performance
1 Week1%
1 Month2%
3 Months13%
6 Months18%
1 Year14%
YTD11%
Moving Average
5 Day SMA913
10 Day SMA918
20 Day SMA925
30 Day SMA939
50 Day SMA941
61 Day SMA944
80 Day SMA966
200 Day SMA1,023
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3935913927938
Resistance 2927911920928
Resistance 1917910916921
Pivot Point909908909911
Support 1900906903903
Support 2892905899894
Support 3883903892886
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqDiv Yld %NP Qtr Rs.Cr.
1SUNPHARMA4,42,18718432%14%2%9%39000
2DIVISLAB1,80,28067912%6%4%1%65000
3TORNTPHARM1,53,28145290%8%18%40%64000
4APOLLOHOSP1,19,04782803%7%12%17%58000
5CIPLA1,14,86914221%10%7%4%22000
6DRREDDY1,11,01513300%1%7%7%20000
7ZYDUSLIFE1,09,37810876%16%15%17%20000
8LUPIN1,04,01722751%2%9%15%23000
9MANKIND1,00,48224343%7%7%2%49000
10MAXHEALTH96,8679957%1%15%14%0000
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Promoters(0.01) 74.87%(0.01) 74.91%(0.01) 74.91%(0.01) 74.94%(0.01) 74.99%(0.01) 75.00%(-7.81) 75.00%(0.01) 82.85%(0.01) 82.85%(0.01) 82.85%(0.01) 82.85%(0.01) 82.85%
FIIs(0.21) 5.30%(-1.81) 5.08%(0.41) 6.84%(-0.21) 6.42%(-0.21) 6.57%(-1.11) 6.74%(3.01) 7.85%(-0.21) 4.81%(0.41) 5.01%(0.21) 4.57%(1.11) 4.39%(0.01) 3.27%
DIIs(0.11) 7.27%(1.71) 7.13%(-0.21) 5.47%(0.41) 5.62%(0.31) 5.19%(0.71) 4.86%(2.61) 4.16%(0.21) 1.57%(0.71) 1.41%(0.11) 0.74%(0.11) 0.64%(0.01) 0.58%
Public12.55%12.89%12.79%13.03%13.25%13.40%12.99%10.76%10.73%11.84%12.13%13.30%
No. of Shareholders127,969132,748135,643138,500141,977146,840143,960149,396156,183185,531198,764208,267
Quarterly Results
Profit and Loss
Mar 2021Mar 2020Mar 2019
Sales18851537886
Expenses12941065639
Operating Profit591472248
OPM %313128
Other Income1120
Interest88341
Depreciation332919
Profit before tax471421228
Tax %252614
Net Profit 352313196
EPS in Rs358.741597.37997.86
Dividend Payout %000
Cash Flows
Mar 2021Mar 2020Mar 2019
Cash from Operating Activity000
Cash from Investing Activity000
Cash from Financing Activity000
Net Cash Flow000
Balance Sheet
Mar 2021Mar 2020Mar 2019
Equity Capital000
Reserves000
Borrowings000
Other Liabilities000
Total Liabilities000
Fixed Assets000
CWIP000
Investments000
Other Assets000
Total Assets000
Delivery
#Date
917
25%
1148
Value (Cr)Q/T
22
Del
57
Del
12
127-May1070
7
10493
226-May1091
18
10387
325-May1050
11
13576
422-May1039
9
7454
521-May1056
4
8552
620-May1061
7
11634
719-May1062
5
8503
818-May1055
11
9606
915-May1045
23
136214
1014-May1064
9
8514
1113-May1081
6
10533
1212-May1099
7
9524
1311-May1126
10
9485
148-May1121
7
9524
157-May1121
17
11549
166-May1125
25
165614
175-May1077
11
10465
184-May1069
14
12507
1930-Apr1038
21
12306
2029-Apr1006
31
267223
2128-Apr1008
20
217715
2227-Apr1045
6
8483
2324-Apr1050
6
10583
2423-Apr1062
5
9422
2522-Apr1057
3
8532
2621-Apr1073
17
176310
2720-Apr1068
9
14535
2817-Apr1070
23
378419
2916-Apr1071
10
15606
3015-Apr1065
12
13638
3113-Apr1046
18
267714
3210-Apr1046
6
7543
339-Apr1043
5
9633
348-Apr1044
11
11455
357-Apr1040
10
17707
366-Apr1006
28
106618
372-Apr990
4
8462
381-Apr984
9
10504
3930-Mar973
6
8443
4027-Mar981
15
12335
4125-Mar985
11
14546
4224-Mar970
7
11493
4323-Mar934
10
14606
4420-Mar950
5
9533
Daily Market Cap
DateTotal Market CapChangeChg %
27-May13,563c7c0.05
26-May13,555c520c3.99
25-May13,035c128c0.99
22-May12,907c201c1.54
21-May13,108c74c0.56
20-May13,035c00
19-May13,035c65c0.50
18-May12,970c265c2.09
15-May12,704c379c2.90
14-May13,084c254c1.90
13-May13,338c211c1.56
12-May13,549c276c2.00
11-May13,825c114c0.83
07-May13,711c230c1.70
06-May13,481c303c2.30
05-May13,178c291c2.26
04-May12,887c26c0.20
30-Apr12,862c477c3.86
29-Apr12,384c55c0.45
28-Apr12,329c492c3.83
24-Apr12,820c225c1.72
23-Apr13,045c96c0.74
22-Apr12,949c246c1.86
21-Apr13,194c145c1.11
17-Apr13,049c272c2.04
15-Apr13,321c00
Stock Checklist
Price is above from 52 week high low average: 41%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0